STERISHEALTHCARE Products
Mumbai info@sterispharma.com
918824175417
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
Home Products MESALMILE 500 PR
MESALMILE 500 PR Me
MESALMILE 500 PR Me
COD not available
GASTROLOGYRANGE by Mesalamine DR (500mg)

MESALMILE 500 PR

INR 179 INR 256
You Save: INR 77 (30.08%)
Check On
Share with
Check On
Share this on :

Description

Product details

MESALMILE 500 PR Mesalamine DR (500mg) Mesalmile 500 PR/Mesalamine DR (500mg): Mesalmile 500 PR, featuring delayed-release Mesalamine (500mg), is a targeted treatment for mild to moderate ulcerative colitis. Its advanced formulation ensures the active ingredient is released directly in the colon, maximizing efficacy while minimizing common gastrointestinal side effects. Ideal for long-term management, it helps reduce inflammation, promoting mucosal healing and symptom relief. Suitable for adults and monitored use in children.

Keywords

Other Products

Related Products

TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function. Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications. Key Indications: TELAVINCE 300 is indicated for: HIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg). Chronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication. Mechanism of Action: Tenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread. Dosage and Administration: Recommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food. For HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen. For Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment. Dosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease. Key Benefits of TELAVINCE 300: Potent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication. Once-Daily Dosing: Improves patient compliance and treatment adherence. Backed by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count). Trusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes. Part of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B. Safety and Precautions: Renal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment. Bone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis. Hepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment. Lactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention. Possible Side Effects: Most patients tolerate TELAVINCE 300 well. However, some may experience: Nausea Diarrhea Headache Fatigue Rash Dizziness Decreased bone mineral density Renal impairment (in rare cases) If any side effects persist or worsen, consult a healthcare professional immediately. Storage Instructions: Store in a cool, dry place below 30°C. Protect from light and moisture. Keep out of reach of children. Why Choose TELAVINCE 300? TELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards. Disclaimer: This product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.
View Details
TELAVINCE 300

INR1480

CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance. Composition Active Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension Brand Name: CEPHODOXIAA 50 DS Form: Oral Suspension Drug Class: Cephalosporin Antibiotic Excipients: Flavors, sweeteners, stabilizers for palatability and suspension stability Cefpodoxime Proxetil Oral Suspension IP Uses CEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections: Respiratory Tract Infections Tonsillitis, Pharyngitis Bronchitis and Pneumonia Ear, Nose & Throat (ENT) Infections Acute Sinusitis Otitis Media (middle ear infection) Urinary Tract Infections (UTIs) Cystitis and kidney infections Skin & Soft Tissue Infections Impetigo, Cellulitis Infected wounds and abscesses Other Indications Gonorrhea (in selected cases) Pediatric bacterial infections where oral dosing is preferred For babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections. How Cefpodoxime Proxetil Oral Suspension Works Cefpodoxime Proxetil is a beta-lactam antibiotic that: Inhibits bacterial cell wall synthesis Weakens bacterial cells, causing cell death Effective against both Gram-positive and Gram-negative bacteria This mechanism helps control infections and prevents their spread. Dosage & Administration Infants & Children: Dose is based on body weight and prescribed by a pediatrician. Commonly 5–10 mg/kg/day, divided into 2 doses daily. Adults: Typically 100–200 mg every 12 hours, depending on infection severity. Administration Tips: Shake the bottle well before use. Use the measuring cup or spoon provided for accurate dosing. Can be taken with or without food, but giving after meals may reduce stomach upset. Complete the full course even if symptoms improve. Benefits of Cefpodoxime Proxetil Oral Suspension Easy to administer for children and babies Broad-spectrum coverage for respiratory, urinary, and skin infections Helps in rapid infection control Safe and effective with minimal side effects when taken as prescribed Suspension form allows accurate weight-based dosing Side Effects of Cefpodoxime Proxetil Oral Suspension Mild side effects may include: Diarrhea or loose stools Nausea or vomiting Stomach pain Headache or dizziness Skin rash or itching Serious side effects (rare): Severe allergic reaction (swelling, rash, difficulty breathing) Severe diarrhea indicating Clostridium difficile infection Liver enzyme elevation Seek medical attention if any severe or persistent side effects occur. Precautions & Warnings Avoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics Use cautiously in patients with kidney or liver disease Not effective against viral infections like flu or common cold Pregnant or breastfeeding women should consult a doctor before use Always complete the full prescribed course to prevent antibiotic resistance Drug Interactions Antacids containing magnesium or aluminum may reduce absorption Proton pump inhibitors (PPIs) like omeprazole Blood thinners (e.g., warfarin – monitor for increased bleeding risk) Other antibiotics may interact and alter effectiveness Conclusion CEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.
View Details
CEPHODOXIAA 50 DS

INR100

PYRITIGMIN RIVA 3 Rivastigmine Capsules IP 3 mg Pyritigmin Riva 3 is a trusted and effective formulation containing Rivastigmine Capsules IP 3 mg, designed to support patients suffering from cognitive decline associated with Alzheimer’s disease and Parkinson’s disease dementia. Manufactured with precision and care by Steris Healthcare, this medication belongs to the class of cholinesterase inhibitors and works by improving communication between nerve cells in the brain. Alzheimer’s disease and Parkinson’s disease dementia are progressive neurological conditions that impair memory, thinking, and overall cognitive function. While there is currently no cure, Pyritigmin Riva 3 offers symptomatic relief by enhancing mental clarity, reducing memory loss, and helping patients maintain daily functional independence for longer. Composition Active Ingredient: Rivastigmine Capsules IP 3 mg Brand Name: Pyritigmin Riva 3 Formulation: Hard gelatin capsules Uses of Rivastigmine Capsules (Pyritigmin Riva 3) Alzheimer’s Disease: Helps reduce memory loss, confusion, and cognitive decline. Parkinson’s Disease Dementia: Improves focus, alertness, and reduces confusion. Mild to Moderate Dementia: Enhances daily living activities and maintains patient independence. Cognitive Function Support: Improves learning ability and attention span. How Does Pyritigmin Riva 3 Work? Rivastigmine, the main component of Pyritigmin Riva 3, works as a cholinesterase inhibitor. It blocks the enzymes acetylcholinesterase and butyrylcholinesterase, which break down acetylcholine—a neurotransmitter essential for memory and learning. By preventing its breakdown, Rivastigmine increases acetylcholine levels in the brain, thereby improving nerve cell communication. This mechanism slows the worsening of symptoms, giving patients more time to maintain their mental functions and quality of life. Dosage and Administration Typical Dose: One capsule of Pyritigmin Riva 3 (Rivastigmine 3 mg) twice daily with food, or as directed by your doctor. Titration: The dose may be adjusted gradually depending on tolerance and effectiveness. Administration: Swallow the capsule whole with a glass of water. Do not crush or chew. Take at the same time each day to maintain stable drug levels. Key Benefits of Pyritigmin Riva 3 Improves Memory Retention – Enhances recall ability and reduces forgetfulness. Slows Symptom Progression – Delays worsening of dementia symptoms. Supports Daily Activities – Helps patients maintain independence in dressing, eating, and communication. Dual Action in Dementia – Effective in both Alzheimer’s disease and Parkinson’s-related dementia. Well-Tolerated Formulation – Designed for safe, effective long-term use. Possible Side Effects Like all medications, Pyritigmin Riva 3 may cause side effects in some individuals. Common Side Effects: Nausea Vomiting Loss of appetite Dizziness Stomach pain Diarrhea Serious Side Effects (rare): Severe weight loss Fainting or irregular heartbeat Seizures Severe allergic reaction (rash, swelling, breathing difficulty) Precautions and Warnings Inform your doctor if you have a history of heart problems, asthma, peptic ulcers, or seizures. Use with caution in patients with low body weight. Avoid alcohol, as it may worsen side effects. Not recommended during pregnancy or breastfeeding unless prescribed by a doctor. Should be used only under strict medical supervision. Drug Interactions Rivastigmine may interact with: Other cholinergic drugs (donepezil, galantamine) – risk of side effects increases. Anticholinergic drugs – reduced effectiveness. Beta-blockers – may increase risk of slow heart rate. NSAIDs (like ibuprofen, aspirin) – may increase stomach irritation risk. Always inform your healthcare provider about all medications you are taking. Why Choose Steris Healthcare for Pyritigmin Riva 3? Steris Healthcare is a leading pharmaceutical company recognized for its commitment to quality, safety, and affordability. By choosing Pyritigmin Riva 3, patients and caregivers can trust: WHO-GMP Certified Manufacturing – Assuring international quality standards. Stringent Quality Control – Every batch is tested for safety and efficacy. Affordable Pricing – Making dementia care accessible for all patients. Pan-India Distribution – Easy availability across pharmacies and hospitals. Patient-Centric Approach – Focused on improving patient outcomes and quality of life. Steris Healthcare ensures that Pyritigmin Riva 3 (Rivastigmine Capsules IP 3 mg) is a reliable, safe, and effective solution for managing dementia-related symptoms.
View Details
Rivastigmine capsules IP 3 mg

INR250

Have any question or need any business consultation?

Contact Us

Have any question or need any business consultation?

Contact Us
Chat with us  

Opening Hours

    Subscribe Us

    Subscribe to our newsletter!
    Steris Healthcare Pvt Ltd

    Social share